Business
British pharmaceutical giant GlaxoSmithKline is dropping the cordial overtures toward its takeover target and occasional business partner Human Genome Sciences Inc.
May 9, 2012
Human Genome Sciences Inc. said it bought Principia Pharmaceutical Corp., a closely held drug development company, for about $120 million in stock.
Sept. 12, 2000
Amgen Inc. of Thousand Oaks acquired rights from Human Genome Sciences Inc. to develop and sell potential treatments for cancer and immune deficiencies.
Jan. 10, 2006
Two companies researching human genes to treat cancer, prevent heart attacks and cure other diseases said Tuesday that they have so many new drug possibilities that they have enlisted two more partners to share the work.
July 3, 1996
Technology and the Internet
Human Genome Sciences Inc. said William Haseltine, renowned for his work in genetic research, would retire as chairman and chief executive from the biotech company he founded as it struggled to successfully develop new drugs.
March 26, 2004
IBM Corp. and Incyte Genomics Inc. have agreed to combine their specialized software into a product companies can use to analyze the human genetic code for drug research.
Sept. 11, 2000
GenStar Therapeutics Corp. and closely held Vascular Genetics Inc. agreed to merge, becoming a biotechnology company focused on gene therapy.
Sept. 14, 2002
Investors have been showing that they still like telecom stocks, but it’s the biotech sector that really pushes their buttons these days.
June 24, 2000
Biotech fever reached a new level Wednesday after Human Genome Sciences Inc.
Feb. 17, 2000
The firm will shift its focus to turning its genetic discoveries into drugs. It’s a riskier but potentially more rewarding realm.
Feb. 13, 2001